Sniffing, rearing and locomotor responses to the D-1 dopamine agonist R-SK&F 38393 and to apomorphine: differential interactions with the selective D-1 and D-2 antagonists SCH 23390 and metoclopramide
- PMID: 3886407
- DOI: 10.1016/0014-2999(85)90454-6
Sniffing, rearing and locomotor responses to the D-1 dopamine agonist R-SK&F 38393 and to apomorphine: differential interactions with the selective D-1 and D-2 antagonists SCH 23390 and metoclopramide
Abstract
The D-1 agonist R-SK&F 38393 induced non-stereotyped sniffing, rearing and locomotor responses that were blocked by the D-1 antagonist SCH 23390. The D-2 antagonist metoclopramide failed to block sniffing but blocked rearing and locomotion. Stereotyped sniffing and locomotion induced by apomorphine were each blocked by both antagonists. Either the criteria by which compounds are designated as D-1 or D-2 selective agents require revision, or else D-1 and D-2 mechanisms are able to reciprocally interact to influence the expression of behaviour initiated by stimulation of either receptor subtype.
Similar articles
-
Dopaminergic behaviour stereospecific promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390.Psychopharmacology (Berl). 1984;82(4):409-10. doi: 10.1007/BF00427697. Psychopharmacology (Berl). 1984. PMID: 6427836
-
The enantiomers of SK&F 83566, a new selective D-1 dopamine antagonist, stereospecifically block stereotyped behaviour induced by apomorphine and by the selective D-2 agonist RU 24213.Eur J Pharmacol. 1985 Oct 8;116(1-2):183-6. doi: 10.1016/0014-2999(85)90202-x. Eur J Pharmacol. 1985. PMID: 4054213
-
Locomotor behaviors in response to new selective D-1 and D-2 dopamine receptor agonists, and the influence of selective antagonists.Pharmacol Biochem Behav. 1986 Jul;25(1):249-53. doi: 10.1016/0091-3057(86)90262-5. Pharmacol Biochem Behav. 1986. PMID: 3529126
-
On the interpretation of asymmetries of posture and locomotion produced with dopamine agonists in animals with unilateral depletion of striatal dopamine.Prog Neurobiol. 1991;36(3):229-56. doi: 10.1016/0301-0082(91)90032-v. Prog Neurobiol. 1991. PMID: 1673254 Review. No abstract available.
-
Behavioural pharmacology of 'D-1-like' dopamine receptors: further subtyping, new pharmacological probes and interactions with 'D-2-like' receptors.Prog Neuropsychopharmacol Biol Psychiatry. 1995 Sep;19(5):811-31. doi: 10.1016/0278-5846(95)00130-n. Prog Neuropsychopharmacol Biol Psychiatry. 1995. PMID: 8539421 Review.
Cited by
-
Opposing actions of D-1 and D-2 dopamine receptor-mediated alterations of adenosine-3',5'-cyclic monophosphate (cyclic AMP) formation during the amphetamine-induced release of endogenous dopamine in vitro.Naunyn Schmiedebergs Arch Pharmacol. 1987 Aug;336(2):133-8. doi: 10.1007/BF00165796. Naunyn Schmiedebergs Arch Pharmacol. 1987. PMID: 2825038
-
Selective D-1 dopamine receptor agonist treatment of Parkinson's disease.J Neural Transm. 1987;68(1-2):41-50. doi: 10.1007/BF01244638. J Neural Transm. 1987. PMID: 2949059 Clinical Trial.
-
Apomorphine-induced alterations in cortical EEG activity of rats. Involvement of D-1 and D-2 dopamine receptors.Naunyn Schmiedebergs Arch Pharmacol. 1989 Dec;340(6 Pt 2):718-25. doi: 10.1007/BF00169680. Naunyn Schmiedebergs Arch Pharmacol. 1989. PMID: 2699354
-
Parametric and pharmacological analyses of the enhanced grooming response elicited by the D1 dopamine receptor agonist SKF 38393 in the rat.Psychopharmacology (Berl). 1992;109(1-2):41-8. doi: 10.1007/BF02245478. Psychopharmacology (Berl). 1992. PMID: 1365670
-
Proceedings of the British Pharmacological Society. Cardiff, 10th-12th April, 1985. Abstracts.Br J Pharmacol. 1985 Jun;85 Suppl(Suppl):204P-393P. Br J Pharmacol. 1985. PMID: 4016435 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous